Kidney function study of afabicin
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how the drug afabicin is processed by the body in people with different levels of kidney function. It helps doctors understand if the dose needs to be adjusted for people with kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your body mass index (BMI) is between 18.5 and 35.
- You are a non-smoker and have not used nicotine products for at least a month.
- You have stable kidney function, which will be checked with a blood test.
- You have not had a recent infection or a history of many infections.
- You have not had chronic pancreatitis or uric acid stones in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
This study tests a new medicine called RO7795081 in people with different levels of kidney function, including those with kidney problems and those with normal kidneys. It aims to see how safe the medicine is and how the body processes it, which helps doctors decide safe dosing for people with kidney issues.
This study looks at how the kidneys work in both healthy people and those with reduced kidney function. Researchers want to understand kidney health better to help people in the future.
This study tests a single dose of an investigational medicine (NNC0537-1482) to see how it moves through the body in people with different levels of kidney function. It may help researchers understand how the drug is processed so it can be dosed safely in future studies.
This study tests an experimental drug called INCB161734 in people with severe kidney disease or those on dialysis. It aims to see how the drug behaves in the body and if it is safe.
Hear when a new Renal Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.